PPARA and metabolic dysfunction-associated steatotic liver disease: In comparison with the findings on wild-type mice (Fig. 2), HDCA intervention failed to improve NAFLD-related parameters in Pparα−/− mice such as body weight, liver TG, hepatic steatosis score, and NAS (Fig. 5a–f).